Alprolix IV 2000, manufactured by Sanofi, contains eftrenonacog alpha (genetically recombination), a recombinant coagulation factor IX concentrate indicated for treating and preventing bleeding episodes in hemophilia B. It is provided as 2,000 IU 1 bottle with dissolving liquid (YJ code: 6343441D3020).
Alprolix IV 2000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →